Shintaro Ichikawa1, Utaroh Motosugi2, Nobuyuki Enomoto3, Hiroshi Onishi1. 1. Department of Radiology, University of Yamanashi, 1110 Shimokato, Chuo-shi, Yamanashi, 409-3898, Japan. 2. Department of Radiology, University of Yamanashi, 1110 Shimokato, Chuo-shi, Yamanashi, 409-3898, Japan. umotosugi@nifty.com. 3. First Department of Internal Medicine, University of Yamanashi, 1110 Shimokato, Chuo-shi, Yamanashi, 409-3898, Japan.
Abstract
OBJECTIVE: To evaluate the usefulness of longitudinal observation of liver stiffness measured using magnetic resonance elastography (MRE) to stratify the risk of hepatocellular carcinoma (HCC) in patients with chronic liver disease. MATERIALS AND METHODS: We retrospectively reviewed data for 161 patients with chronic liver disease using the following inclusion criteria: two MRE examinations separated by at least a 12-month interval, no history of HCC, no development of HCC between the two examinations and availability of laboratory results. Liver stiffness was classified as low (< 3 kPa), moderate (3-4.7 kPa) or high (> 4.7 kPa). The patients were divided into three groups according to sequential changes in liver stiffness as follows: high on the first MRE (group A, n = 60), low on both MRE examinations (group C, n = 36) and other combinations (group B, n = 65). Cox analyses and Kaplan-Meier methods were used to determine the risk of developing HCC. RESULTS: Forty-seven patients (29.2%) developed HCC during follow-up (46.7% [28/60] in group A, 26.2% [17/65] in group B, and 5.6% [2/36] in group C). There was a significant difference in the rate of development of HCC between groups A (45.1%), B (26.1%) and C (12.4%) at 3 years (p = 0.0002). The independent risk factors for development of HCC were group A classification, age and a high alanine aminotransferase level (risk ratio 1.018-6.030; p = 0.0028-0.0268). CONCLUSION: Longitudinal observation of liver stiffness using MRE can stratify the risk of HCC during follow-up of chronic liver disease. KEY POINTS: • The results of MRE can stratify the risk for development of HCC during follow-up in patients with chronic liver disease. • Patients with chronic liver disease and high liver stiffness (> 4.7 kPa) on a previous MRE examination are at high risk for developing HCC, regardless of current liver stiffness. • Management of patients with chronic liver disease becomes more appropriate using longitudinally acquired two-point MRE data.
OBJECTIVE: To evaluate the usefulness of longitudinal observation of liver stiffness measured using magnetic resonance elastography (MRE) to stratify the risk of hepatocellular carcinoma (HCC) in patients with chronic liver disease. MATERIALS AND METHODS: We retrospectively reviewed data for 161 patients with chronic liver disease using the following inclusion criteria: two MRE examinations separated by at least a 12-month interval, no history of HCC, no development of HCC between the two examinations and availability of laboratory results. Liver stiffness was classified as low (< 3 kPa), moderate (3-4.7 kPa) or high (> 4.7 kPa). The patients were divided into three groups according to sequential changes in liver stiffness as follows: high on the first MRE (group A, n = 60), low on both MRE examinations (group C, n = 36) and other combinations (group B, n = 65). Cox analyses and Kaplan-Meier methods were used to determine the risk of developing HCC. RESULTS: Forty-seven patients (29.2%) developed HCC during follow-up (46.7% [28/60] in group A, 26.2% [17/65] in group B, and 5.6% [2/36] in group C). There was a significant difference in the rate of development of HCC between groups A (45.1%), B (26.1%) and C (12.4%) at 3 years (p = 0.0002). The independent risk factors for development of HCC were group A classification, age and a high alanine aminotransferase level (risk ratio 1.018-6.030; p = 0.0028-0.0268). CONCLUSION: Longitudinal observation of liver stiffness using MRE can stratify the risk of HCC during follow-up of chronic liver disease. KEY POINTS: • The results of MRE can stratify the risk for development of HCC during follow-up in patients with chronic liver disease. • Patients with chronic liver disease and high liver stiffness (> 4.7 kPa) on a previous MRE examination are at high risk for developing HCC, regardless of current liver stiffness. • Management of patients with chronic liver disease becomes more appropriate using longitudinally acquired two-point MRE data.
Entities:
Keywords:
Hepatocellular carcinoma; Magnetic resonance elastography; Observation; Risk assessment
Authors: Y Shiratori; F Imazeki; M Moriyama; M Yano; Y Arakawa; O Yokosuka; T Kuroki; S Nishiguchi; M Sata; G Yamada; S Fujiyama; H Yoshida; M Omata Journal: Ann Intern Med Date: 2000-04-04 Impact factor: 25.391
Authors: A Manduca; T E Oliphant; M A Dresner; J L Mahowald; S A Kruse; E Amromin; J P Felmlee; J F Greenleaf; R L Ehman Journal: Med Image Anal Date: 2001-12 Impact factor: 8.545
Authors: H Yoshida; Y Shiratori; M Moriyama; Y Arakawa; T Ide; M Sata; O Inoue; M Yano; M Tanaka; S Fujiyama; S Nishiguchi; T Kuroki; F Imazeki; O Yokosuka; S Kinoyama; G Yamada; M Omata Journal: Ann Intern Med Date: 1999-08-03 Impact factor: 25.391
Authors: Olivier Rouvière; Meng Yin; M Alex Dresner; Phillip J Rossman; Lawrence J Burgart; Jeff L Fidler; Richard L Ehman Journal: Radiology Date: 2006-08 Impact factor: 11.105
Authors: Meng Yin; Jayant A Talwalkar; Kevin J Glaser; Armando Manduca; Roger C Grimm; Phillip J Rossman; Jeff L Fidler; Richard L Ehman Journal: Clin Gastroenterol Hepatol Date: 2007-10 Impact factor: 11.382
Authors: Jayant A Talwalkar; Meng Yin; Sudhakar Venkatesh; Phillip J Rossman; Roger C Grimm; Armando Manduca; Anthony Romano; Patrick S Kamath; Richard L Ehman Journal: AJR Am J Roentgenol Date: 2009-07 Impact factor: 3.959